Sonoko Kawakatsu

Associate Director
Gilead Sciences, Inc.

Poster(s):

• (M-094) Population Pharmacokinetic Analysis of Zimberelimab in Patients with Solid Tumors
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT